Beijing Tong Ren Tang Chinese Medicine (3613.HK) Earnings Analysis
Beijing Tong Ren Tang Chinese Medicine (3613.HK) next reports earnings on 2026-08-07. Trailing P/E 14.24.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does 3613.HK next report earnings?
| Next earnings date | 2026-08-07 |
|---|---|
| Consensus EPS estimate | n/a |
| Revenue estimate | n/a |
3613.HK earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2025-08-22 | 0.28 HKD | n/a | n/a | n/a |
| 2024-12-31 | 0.1675 HKD | n/a | n/a | n/a |
| 2024-08-30 | 0.1313 HKD | n/a | n/a | n/a |
3613.HK valuation and analyst view
| Trailing P/E | 14.24 |
|---|---|
| Trailing EPS | 0.47451 HKD |
| Price / book | 1.35 |
| Dividend yield | 5.93% |
| Market cap | 5.68B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is Beijing Tong Ren Tang Chinese Medicine (3613.HK)'s next earnings date?
Beijing Tong Ren Tang Chinese Medicine is next scheduled to report on 2026-08-07.
Did 3613.HK beat earnings last quarter?
Consensus estimate data was not available for 3613.HK's 2025-08-22 report.
What is 3613.HK's current P/E ratio and EPS?
3613.HK trades at a trailing P/E of 14.24 on trailing EPS of 0.47451102897325287 HKD.
What do analysts rate 3613.HK?
3613.HK has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.